OTCMKTS:OSIR Osiris Therapeutics (OSIR) Stock Forecast, Price & News $18.99 0.00 (0.00%) (As of 04/17/2019) Add Compare Share Share Today's Range$18.99▼$18.9950-Day Range$18.99▼$18.9952-Week Range$7.01▼$19.30VolumeN/AAverage Volume205,753 shsMarket Capitalization$655.69 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC Filings About Osiris Therapeutics (OTCMKTS:OSIR) StockOsiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.Read More Receive OSIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Osiris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address OSIR Stock News HeadlinesMay 30, 2023 | finance.yahoo.comTissue Engineering Global Market Report 2023May 23, 2023 | finance.yahoo.comGlobal Cell Therapy Market Report 2023: Growing Approvals for Cell-based Therapies Fuels the SectorJune 3, 2023 | Legacy Research (Affiliate) (Ad)The “Amazon Secret Royalty Program” Can Help Anyone Retire Like RoyaltyA unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.May 23, 2023 | americanbankingnews.comReviewing Osiris Therapeutics (OTCMKTS:OSIR) and REGENXBIO (NASDAQ:RGNX)May 22, 2023 | markets.businessinsider.comVesselon Discovery Protects and Expands Drug FranchisesMay 17, 2023 | marketwatch.comBiological Derived Devices Market Reports, Scope, Methodology, Timelines And Challenges Forecast Till 2030May 17, 2023 | marketwatch.comAllogeneic Stem Cells Market Research Report Analysis the Regions, and International Markets Forecast (2023-2030)May 17, 2023 | marketwatch.comGlobal Stem Cells Market [2023-2030] | Growth Rate (CAGR) at a 10.9% | Expected to Reach Worth 5727.2June 3, 2023 | Legacy Research (Affiliate) (Ad)The “Amazon Secret Royalty Program” Can Help Anyone Retire Like RoyaltyA unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.May 17, 2023 | marketwatch.comStem Cells Market Size Will Have Significant Potential in Future Reaching Over USD 37,800 Million by 2032May 16, 2023 | marketwatch.comStem Cells Market Growth Opportunities Till 2030May 12, 2023 | marketwatch.comTissue Engineering Market Size in 2023-2030: Competitive landscape and Leading CountryMay 11, 2023 | marketwatch.comCartilage Repair& Cartilage Regeneration Market Forecast 2023-2030May 9, 2023 | marketwatch.comStem Cell Therapy Market Outlook and Forecast till 2030May 9, 2023 | marketwatch.com2030, Stem Cell Therapy Market: Growth & StatisticsMay 8, 2023 | marketwatch.comStem Cell Therapy Market Research | 2023-2030May 8, 2023 | marketwatch.comGlobal Allograft Market by [2023-2029] with Revenue OutsourcingMay 5, 2023 | marketwatch.comGraft Versus Host Disease (GVHD) Treatment Market by Product Type and Consumers-2030May 4, 2023 | marketwatch.comGlobal Stem Cell Therapy Market [2023-2030] | Growing at a CAGR of 19.7% | An Overview of Market Trends and ProjectionsMay 3, 2023 | marketwatch.comAllogeneic Stem Cells Market Growth and Size 2031May 2, 2023 | marketwatch.comExploring the Growth Potential of the Regenerative Medicine Products Market till 2031April 30, 2023 | marketwatch.comActive Wound Care Market Size, Share, Growth Rate, Geographic Segmentation, Key Players Analysis To 2030April 29, 2023 | marketwatch.comDiabetic Foot Ulcer Therapeutics Market Growth by 2030April 29, 2023 | marketwatch.comGlobal Stem Cell Therapy Market by [2023-2029] with Revenue OutsourcingApril 28, 2023 | marketwatch.comGlobal Active Wound Care Market Size, Share and Trend Analysis 2028April 28, 2023 | marketwatch.comAllogeneic Stem Cells Market: Segments Analysis and Future Growth Trends By 2030April 27, 2023 | marketwatch.comPancreatic Beta-Cell Protection Market Top Key Players by 2031See More Headlines OSIR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Biological Products, Except Diagnostic Sub-IndustryBiotechnology SectorMedical Current SymbolOTCMKTS:OSIR Previous SymbolNASDAQ:OSIR CUSIP68827R10 CIK1360886 Webwww.osiristx.com Phone443-545-1800FaxN/AEmployeesN/AYear Founded1992Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares34,528,000Free FloatN/AMarket Cap$655.69 million OptionableOptionable BetaN/A Social Links Key ExecutivesMr. Jason Keefer (Age 46)Interim Pres & CEO Dr. Alla N. Danilkovitch (Age 54)Chief Scientific Officer Mr. Joel David Rogers (Age 56)Interim Chief Financial Officer Mr. Edward YipChief Legal Officer & Corp. Sec.Mr. Laine DyessVP of SalesKey CompetitorsNovavaxNASDAQ:NVAXAgenusNASDAQ:AGENSangamo TherapeuticsNASDAQ:SGMOBioCryst PharmaceuticalsNASDAQ:BCRXHilleVaxNASDAQ:HLVXView All Competitors OSIR Stock - Frequently Asked Questions How have OSIR shares performed in 2023? Osiris Therapeutics' stock was trading at $18.99 at the beginning of 2023. Since then, OSIR shares have increased by 0.0% and is now trading at $18.99. View the best growth stocks for 2023 here. What other stocks do shareholders of Osiris Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Osiris Therapeutics investors own include Sierra Wireless (SWIR), Achillion Pharmaceuticals (ACHN), Fate Therapeutics (FATE), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Aerie Pharmaceuticals (AERI), Cytokinetics (CYTK) and Depomed (DEPO). What is Osiris Therapeutics' stock symbol? Osiris Therapeutics trades on the OTCMKTS under the ticker symbol "OSIR." How do I buy shares of Osiris Therapeutics? Shares of OSIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Osiris Therapeutics' stock price today? One share of OSIR stock can currently be purchased for approximately $18.99. How much money does Osiris Therapeutics make? Osiris Therapeutics (OTCMKTS:OSIR) has a market capitalization of $655.69 million. How can I contact Osiris Therapeutics? Osiris Therapeutics' mailing address is 7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD, 21046. The official website for the company is www.osiristx.com. The biotechnology company can be reached via phone at 443-545-1800 or via email at osirispr@osiris.com. This page (OTCMKTS:OSIR) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Osiris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.